These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 24740878)

  • 21. The impact of VPS35 D620N mutation on alternative autophagy and its reversal by estrogen in Parkinson's disease.
    Shiraishi T; Bono K; Hiraki H; Manome Y; Oka H; Iguchi Y; Okano HJ
    Cell Mol Life Sci; 2024 Feb; 81(1):103. PubMed ID: 38409392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p.D620N.
    Munsie LN; Milnerwood AJ; Seibler P; Beccano-Kelly DA; Tatarnikov I; Khinda J; Volta M; Kadgien C; Cao LP; Tapia L; Klein C; Farrer MJ
    Hum Mol Genet; 2015 Mar; 24(6):1691-703. PubMed ID: 25416282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the VPS35 D620N mutation in Parkinson's disease.
    Mohan M; Mellick GD
    Parkinsonism Relat Disord; 2017 Mar; 36():10-18. PubMed ID: 27964832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP.
    Jiang M; Tu HT; Zhang K; Zhang W; Yu WP; Xu J; Tan EK; Guo KH; Zeng L
    Neurobiol Dis; 2021 Jun; 153():105313. PubMed ID: 33636388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VPS35 pathogenic mutations confer no dominant toxicity but partial loss of function in Drosophila and genetically interact with parkin.
    Malik BR; Godena VK; Whitworth AJ
    Hum Mol Genet; 2015 Nov; 24(21):6106-17. PubMed ID: 26251041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deciphering the role of VPS35 in Parkinson's disease.
    Williams ET; Moore DJ
    J Neurosci Res; 2018 Aug; 96(8):1339-1340. PubMed ID: 29775219
    [No Abstract]   [Full Text] [Related]  

  • 27. Mutant VPS35-D620N induces motor dysfunction and impairs DAT-mediated dopamine recycling pathway.
    Huang Y; Huang H; Zhou L; Li J; Chen X; Thomas J; He X; Guo W; Zeng Y; Low BC; Liang F; Zeng J; Ross CA; Tan EK; Smith W; Pei Z
    Hum Mol Genet; 2022 Nov; 31(22):3886-3896. PubMed ID: 35766879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VPS35 mutation in Japanese patients with typical Parkinson's disease.
    Ando M; Funayama M; Li Y; Kashihara K; Murakami Y; Ishizu N; Toyoda C; Noguchi K; Hashimoto T; Nakano N; Sasaki R; Kokubo Y; Kuzuhara S; Ogaki K; Yamashita C; Yoshino H; Hatano T; Tomiyama H; Hattori N
    Mov Disord; 2012 Sep; 27(11):1413-7. PubMed ID: 22991136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function.
    Tang FL; Liu W; Hu JX; Erion JR; Ye J; Mei L; Xiong WC
    Cell Rep; 2015 Sep; 12(10):1631-43. PubMed ID: 26321632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.
    Miura E; Hasegawa T; Konno M; Suzuki M; Sugeno N; Fujikake N; Geisler S; Tabuchi M; Oshima R; Kikuchi A; Baba T; Wada K; Nagai Y; Takeda A; Aoki M
    Neurobiol Dis; 2014 Nov; 71():1-13. PubMed ID: 25107340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contributions of VPS35 Mutations to Parkinson's Disease.
    Rahman AA; Morrison BE
    Neuroscience; 2019 Mar; 401():1-10. PubMed ID: 30660673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation.
    McGough IJ; Steinberg F; Jia D; Barbuti PA; McMillan KJ; Heesom KJ; Whone AL; Caldwell MA; Billadeau DD; Rosen MK; Cullen PJ
    Curr Biol; 2014 Jul; 24(14):1670-1676. PubMed ID: 24980502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's Disease Causative Mutation in Vps35 Disturbs Tetherin Trafficking to Cell Surfaces and Facilitates Virus Spread.
    Ding Y; Li Y; Chhetri G; Peng X; Wu J; Wang Z; Zhao B; Zhao W; Li X
    Cells; 2021 Mar; 10(4):. PubMed ID: 33800686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.
    Kalinderi K; Bostantjopoulou S; Katsarou Z; Dimikiotou M; Fidani L
    Neurosci Lett; 2015 Oct; 606():113-6. PubMed ID: 26300542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of retromer transport carriers is disrupted by the Parkinson disease-linked Vps35 D620N variant.
    Cui Y; Yang Z; Flores-Rodriguez N; Follett J; Ariotti N; Wall AA; Parton RG; Teasdale RD
    Traffic; 2021 Apr; 22(4):123-136. PubMed ID: 33347683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression levels of the D686N Parkinson's disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeast.
    Huang Y; Chen X; He X; Guo C; Sun X; Liang F; Long S; Lu X; Feng L; Guo W; Zeng Y; Pei Z
    Mol Med Rep; 2017 Jul; 16(1):254-262. PubMed ID: 28487947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2.
    Yun SP; Kim H; Ham S; Kwon SH; Lee GH; Shin JH; Lee SH; Ko HS; Lee Y
    Cell Death Dis; 2017 Apr; 8(4):e2741. PubMed ID: 28383562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic mutation in VPS35 impairs its protection against MPP(+) cytotoxicity.
    Bi F; Li F; Huang C; Zhou H
    Int J Biol Sci; 2013; 9(2):149-55. PubMed ID: 23411763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila.
    Inoshita T; Arano T; Hosaka Y; Meng H; Umezaki Y; Kosugi S; Morimoto T; Koike M; Chang HY; Imai Y; Hattori N
    Hum Mol Genet; 2017 Aug; 26(15):2933-2948. PubMed ID: 28482024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased copper toxicity in Saccharomyces cerevisiae lacking VPS35, a component of the retromer and monogenic Parkinson disease gene in humans.
    Sowada N; Stiller B; Kubisch C
    Biochem Biophys Res Commun; 2016 Aug; 476(4):528-533. PubMed ID: 27262440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.